Zhengye Biotechnology Holding Limited (ZYBT)

NASDAQ: ZYBT · Real-Time Price · USD

0.8501

-0.0564 (-6.22%)

Apr 2, 2026, 9:31 AM EDT - Market open

ZYBT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.24	0.25	0.27	0.18	0.09
Debt / EBITDA Ratio	-	2.13	1.30	0.77	0.44
Debt / FCF Ratio	280.27	3.15	2.20	-	2.35
Net Debt / Equity Ratio	0.10	0.19	0.22	0.15	0.07
Net Debt / EBITDA Ratio	-17.23	1.64	1.07	0.65	0.35
Net Debt / FCF Ratio	124.62	2.42	1.80	-5.52	1.86
Asset Turnover	0.31	0.38	0.42	0.54	-
Inventory Turnover	1.62	1.63	1.66	2.27	-
Quick Ratio	1.00	0.80	0.77	0.95	0.86
Current Ratio	1.49	1.31	1.26	1.41	1.31
Return on Equity (ROE)	-6.38%	3.89%	10.78%	16.50%	-
Return on Assets (ROA)	-3.45%	2.07%	5.51%	8.53%	-
Return on Invested Capital (ROIC)	-6.78%	3.70%	9.35%	15.22%	13.41%
Return on Capital Employed (ROCE)	-7.40%	4.60%	12.90%	17.90%	16.40%
Payout Ratio	-	141.66%	125.42%	45.84%	28.36%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q